View Older Stories View More Recent Stories

Dec 17, 2024 06:16AM Eli Lilly & Co. (LLY) and EVA Pharma announce regulatory approval and release of locally manufactured insulin in Egypt

Dec 15, 2024 06:57PM Innovent and Eli Lilly Expand Collaboration

Dec 13, 2024 10:56AM Ozempic Study Found Small Number Of Patients With Vision Loss - Bloomberg

Dec 13, 2024 08:12AM Eli Lilly's (LLY) Omvoh recommended by CHMP for approval in EU

Dec 13, 2024 06:32AM Bernstein: 'GLP-1s vs. the Weight of the World'

Dec 12, 2024 06:23AM Bernstein Sees Eli Lilly (LLY) 'In a Strong Position to Work Creatively With the New Administration'

Dec 11, 2024 09:44AM Truist: 'Potential Impact of Trump's Nominees on Biopharma'

Dec 11, 2024 08:16AM Eli Lilly & Co. (LLY) Reports Imlunestrant Significantly Improved Progression-Free Survival as Monotherapy and in Combination with Verzenio

Dec 11, 2024 08:13AM Hims & Hers Health, Inc. (HIMS) falls 7% as Ro says it is working with Eli Lilly to streamline access to Zepbound

Dec 9, 2024 04:49PM After-hours movers: Oracle, MongoDB, C3 AI, Lilly and more

Dec 9, 2024 04:19PM Eli Lilly & Co. (LLY) Raises Quarterly Dividend 15.4% to $1.50; 0.7% Yield

Dec 9, 2024 04:17PM Lilly (LLY) announces new $15 billion share repurchase program and seventh consecutive 15% dividend increase

Dec 9, 2024 07:00AM Bernstein: 'Could the lion's share of China GLP-1 market go to domestic players?'

Dec 5, 2024 03:30PM Lilly (LLY) announces $3 billion expansion of its recently acquired manufacturing facility in Wisconsin

Dec 5, 2024 12:03PM Trump hosted the chief executives of Pfizer (PFE), Eli Lilly & Co. (LLY) - Axios

Dec 5, 2024 11:54AM Zepbound vs Wegovy: 'Eli Lilly reinforces its (expected) superiority'

Dec 4, 2024 08:50AM BMO Capital: Five Key BioPharma Catalysts Through Year-End '24

Dec 4, 2024 06:46AM Eli Lilly & Co's (LLY) Zepbound superior to Wegovy in head-to-head trial showing an average weight loss of 20.2% vs. 13.7%

Dec 2, 2024 02:46PM Lilly Products Show Strength Heading Into the Holiday

Nov 30, 2024 04:00AM Is Trump 2.0 good or bad for healthcare stocks?

Nov 27, 2024 06:34AM Erste Group Downgrades Eli Lilly (LLY) to Hold

Nov 26, 2024 07:11AM Amgen (AMGN) Falls 8% Following Obesity Data, Rivals Lilly (LLY), Novo Nordisk (NVO) Gain 4%

Nov 26, 2024 06:09AM Eli Lilly & Co. (LLY) and Novo Nordisk (NVO) gain on Biden's GLP-1 proposal

Nov 26, 2024 05:54AM Eli Lilly & Co. (LLY) call put ratio 1.9 calls to 1 put as share price up before the bell

Nov 20, 2024 07:00PM TD Cowen analyst says FDA decision on this popular weight-loss drug could signal market shift

Nov 19, 2024 04:30PM Eli Lilly & Co. (LLY) Announces Board Changes

Nov 19, 2024 04:30PM Eli Lilly & Co. (LLY) Announces Board Changes

Nov 19, 2024 11:00AM JPM just added these stocks to its Analyst Focus List - giving one 148% upside

Nov 18, 2024 02:10PM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY)

Nov 14, 2024 03:40PM Moderna (MRNA), Others on Watch Following Report Trump Expected to Select Robert F. Kennedy Jr. to lead HHS

Nov 1, 2024 08:30AM Citi is 'aggressively' buying selloff in this pharma stock

Oct 31, 2024 08:59AM Eli Lilly (LLY) PT Lowered to $1,010 at BMO Capital

Oct 31, 2024 08:14AM Eli Lilly (LLY) PT Lowered to $1,029 at Truist Securities

Oct 30, 2024 06:48AM Eli Lilly & Co. (LLY) Misses Q3 EPS by 27c; guides below consensus

Oct 29, 2024 12:17PM Eli Lilly & Co. (LLY) Reports Modified Titration of Donanemab Demonstrated Reduction of ARIA-E in Early Symptomatic Alzheimer's Disease Patients in Phase 3b study

Oct 29, 2024 10:59AM Eli Lilly & Co. (LLY) November 1 weekly option implied volatility into quarter results

Oct 29, 2024 06:07AM Eli Lilly & Co. (LLY) call put ratio 1.7 calls to 1 put into quarter results

Oct 28, 2024 11:33AM Eli Lilly & Co. (LLY) Declares $1.30 Quarterly Dividend; 0.6% Yield

Oct 28, 2024 06:46AM Eli Lilly's (LLY) mirikizumab is first and only IL23p19 antagonist to report long-term, multi-year, sustained efficacy and safety data for both ulcerative colitis and Crohn's disease

Oct 25, 2024 06:45AM Eli Lilly & Co. (LLY) Reports EBGLYSS demonstrated meaningful improvement in skin clearance and itch relief in the majority of patients with moderate-to-severe atopic dermatitis who discontinued dupil

Oct 17, 2024 06:07AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)

Oct 16, 2024 11:00AM This pharma stock could deliver a beat and raise quarter, according to Wells Fargo

Oct 14, 2024 08:24AM Hims & Hers (HIMS) Climbs as FDA to Reconsider Decision Barring Compounded Versions of Eli Lilly (LLY) Weight Loss Drug

Oct 14, 2024 06:45AM Eli Lilly & Co. (LLY) reports one-year histologic outcomes in Phase 3 study of mirikizumab compared to ustekinumab for Crohn's disease

Oct 14, 2024 06:19AM Leerink Partners Reiterates Outperform Rating on Eli Lilly (LLY)

Oct 10, 2024 07:06AM Eli Lilly (LLY) PT Raised to $1,033 at Truist Securities

Oct 8, 2024 02:25PM Obesity Drug Coverage Could Boost Spending By $35B Through 2034: CBO

Oct 7, 2024 09:18AM TD Cowen Reiterates Buy Rating on Eli Lilly (LLY)

Oct 3, 2024 11:12AM Attor­ney Gen­er­al Ken Pax­ton Sues Big Phar­ma Drug Man­u­fac­tur­ers and Phar­ma­cy Ben­e­fit Man­agers for Con­spir­a­cy That Increased Insulin Prices by 1,000%

Oct 3, 2024 07:52AM BMO Capital Reiterates Outperform Rating on Eli Lilly (LLY) After FDA Says Tirzepatide is No Longer on Shortage Lists

View More Recent Stories View Older Stories